EBV gp350 Envelope Protein Activators
EBV gp350 Envelope Protein Activators encompass a diverse group of compounds that indirectly promote the functional activity of the EBV gp350 Envelope Protein through various cellular pathways. Quercetin and Caffeine, by inhibiting phosphodiesterases, lead to increased levels of cAMP, which in turn activates PKA signaling. This activation can potentiate the fusion capacity of the EBV gp350 Envelope Protein with host cell membranes, an essential step in viral entry. Similarly, Forskolin's direct stimulation of adenylyl cyclase raises cAMP levels, further endorsing this enhancement. Sildenafil augments the NO/cGMP/PKG pathway, potentially increasing the fusogenic activity of the protein. Capsaicin, through activation of TRPV1 channels,EBV gp350 Envelope Protein Activators encompass a diverse group of compounds that indirectly promote the functional activity of the EBV gp350 Envelope Protein through various cellular pathways. Quercetin and Caffeine, by inhibiting phosphodiesterases, lead to increased levels of cAMP, which in turn activates PKA signaling.
This activation can potentiate the fusion capacity of the EBV gp350 Envelope Protein with host cell membranes, an essential step in viral entry. Similarly, Forskolin's direct stimulation of adenylyl cyclase raises cAMP levels, further endorsing this enhancement. Sildenafil augments the NO/cGMP/PKG pathway, potentially increasing the fusogenic activity of the protein. Capsaicin, through activation of TRPV1 channels, initiates downstream signaling events that could enhance membrane fusion involving the EBV gp350 Envelope Protein. Resveratrol and Nicotinamide modulate sirtuin and metabolism-related pathways, which could indirectly affect the processing and function of the EBV gp350 Envelope Protein, potentially optimizing its incorporation into viral particles and enhancing infectivity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin inhibits phosphodiesterase (PDE), leading to an increase in intracellular cAMP levels. Elevated cAMP enhances the PKA signaling pathway, which can increase the functional activity of the EBV gp350 Envelope Protein by promoting its fusion capacity with host membranes. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which positively impacts cellular metabolism and stress response pathways. Activation of SIRT1 can enhance the incorporation of the EBV gp350 Envelope Protein into viral particles, optimizing the infectivity process. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin modulates the NF-κB pathway, which is pivotal for immune signaling. By modulating this pathway, Curcumin may enhance the expression of EBV gp350 Envelope Protein on the surface of infected cells, facilitating its activity in viral entry. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits DNA methyltransferases, potentially leading to demethylation of viral DNA and enhanced expression of the EBV gp350 Envelope Protein, indirectly increasing the efficiency of virus binding to susceptible cells. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Capsaicin activates TRPV1 channels, which can lead to downstream effects on cellular signaling pathways, such as the calcium signaling pathway. Increased calcium signaling could enhance the membrane fusion process involving EBV gp350 Envelope Protein. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine inhibits PDE, increasing cAMP levels similarly to Quercetin. This elevation of cAMP may enhance the PKA pathway and indirectly promote EBV gp350 Envelope Protein-mediated membrane fusion events. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide is a sirtuin inhibitor that can modulate cellular metabolism and longevity pathways, potentially affecting the processing and function of the EBV gp350 Envelope Protein in the viral lifecycle. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3). Inhibition of GSK-3 may stabilize cellular factors that assist in the glycosylation and proper folding of the EBV gp350 Envelope Protein, enhancing its activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly activates adenylyl cyclase, increasing intracellular cAMP levels, which in turn can enhance PKA-mediated signaling. This may lead to improved functionality of the EBV gp350 Envelope Protein in viral attachment and entry. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression through nuclear receptors. This modulation could enhance the expression or post-translational modification of the EBV gp350 Envelope Protein, leading to greater functional activity during viral entry. | ||||||